title: Percutaneous transluminal coronary angioplasty in octogenarians.
abstract: OBJECTIVE
  To assess the safety and short- and long-term outcomes of percutaneous transluminal coronary angioplasty in octogenarians.
  
  
  METHODS
  Retrospective chart review of clinical series.
  
  
  METHODS
  Referral-based university medical center.
  
  
  METHODS
  Consecutive series of 54 octogenarian patients (mean age, 82.4 years) who had percutaneous transluminal coronary angioplasty between March 1980 and December 1988. Of these patients, 91% presented with severe angina (Canadian Cardiovascular Society Class III or IV); 59% had unstable angina. Twenty-six patients (48%) had had a previous myocardial infarction and 15 (28%) had had previous coronary artery bypass surgery. Multivessel disease was present in 44 patients (81%). Follow-up ranged from 1 to 50 months (mean, 19 months).
  
  
  METHODS
  Percutaneous transluminal coronary angioplasty.
  
  
  RESULTS
  The angiographic success rate was 50 of 54 (93%; 95% CI, 81% to 98%) and the clinical success rate was 49 of 54 (91%; CI, 79% to 97%). Two patients had procedure-related myocardial infarction. Two patients died in the hospital, 1 from cardiac tamponade because of pacemaker perforation and 1 from cardiogenic shock after a myocardial infarction despite successful angioplasty. During the follow-up period 4 patients required bypass surgery, 2 had myocardial infarction, and 7 died (4 deaths were cardiac). Eleven patients (20%) had re-stenosis, 7 of whom were managed with repeat angioplasty, including 1 patient who had four procedures. At follow-up, 42 of 45 survivors (93%) were asymptomatic or had class II angina. The Kaplan-Meier survival for all patients, including those who died in the hospital, was 87% at 1 year and 80% at 3 years. Cumulative freedom from major cardiac events (death, myocardial infarction, or coronary bypass surgery) was 81% at 1 year and 78% at 3 years.
  
  
  CONCLUSIONS
  Percutaneous transluminal coronary angioplasty can be done in octogenarians with a high rate of angiographic and clinical success, low complication rate, and a favorable long-term (3-year) outcome. As such, it is a treatment option in managing advanced coronary artery disease in this fragile group of patients.
authors.affiliation: Baylor College of Medicine, Methodist Hospital, Houston, Texas.
authors.forename: M O
authors.initials: MO
authors.lastname: Jeroudi
authors.forename: N S
authors.initials: NS
authors.lastname: Kleiman
authors.forename: S T
authors.initials: ST
authors.lastname: Minor
authors.forename: K R
authors.initials: KR
authors.lastname: Hess
authors.forename: J M
authors.initials: JM
authors.lastname: Lewis
authors.forename: W L
authors.initials: WL
authors.lastname: Winters
authors.forename: A E
authors.initials: AE
authors.lastname: Raizner
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D016001:Confidence Intervals; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000601:surgery / Q000628:therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D012008:Recurrence; D012189:Retrospective Studies